We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
ACROBiosystems  Logo

ACROBiosystems

ACROBiosystems is a cornerstone enterprise of the pharmaceutical and biotechnology industries. Our mission is to help overcome challenges with innovative tools and solutions from discovery to the clinic. We supply life science tools designed for discovery research and scalable to the clinical phase and beyond. By consistently adapting to new regulatory challenges and guidelines, we deliver solutions, whether it comes through recombinant proteins, antibodies, assay kits, GMP-grade reagents, or custom services. We empower scientists and engineers dedicated to innovation to simplify and accelerate the development of new, better, and more affordable medicine. Our way of addressing challenges in biologics development is to offer a comprehensive array of tools and solutions designed for each development phase. Starting from discovery and development and moving beyond commercialization, we strive to deliver high-quality solutions that support each step of the development process. This means bringing together innovation and technology through product development and collaborations to help our customers achieve translatable results in the clinic and beyond.

Latest ACROBiosystems Content

Drug Targets
Poster

Accelerating the Discovery of Transmembrane Protein-Targeting Drugs

Drug discovery is a time-consuming, resource-intensive part of developing therapeutic targets. This is especially true for commonly considered 'undruggable' targets such as transmembrane proteins.
Diving Deep Into Cell Therapy: An Industry Perspective content piece image
Whitepaper

Diving Deep Into Cell Therapy: An Industry Perspective

Active cell therapy drugs represent the latest in cancer treatment. Of these, chimeric antigen receptor (CAR) cell modalities are considered the most successful.
Targeting the TME and the Development of Effective Therapeutics Against Solid Tumors content piece image
Video

Targeting the TME and the Development of Effective Therapeutics Against Solid Tumors

Speaking at The Landscape of Cancer Research 2021, Prajwal Paudel from ACROBiosystems delivered their talk on the development of effective therapeutics against solid tumors.
ACROBiosystems Efforts and Collaborations in Cancer Immunotherapy content piece image
Webinar

ACROBiosystems Efforts and Collaborations in Cancer Immunotherapy

On-Demand
Speaking at The Landscape of Cancer Research 2022, Nicholas Abuid, PhD from ACROBiosystems, presented his talk on providing high purity, customizable, and bioactive reagents to support research and translation in cancer immune therapy. Their catalogue ranges in targets for various diseases.
Discovery Solutions for Cell and Gene Therapy content piece image
Product
Advertisement

Discovery Solutions for Cell and Gene Therapy

As a leading manufacturer of recombinant proteins and other critical reagents to support the development of biomedicine, ACROBiosystems is proud to stand by you in the CGT journey.
Full Length Active Gallery content piece image
Product
Advertisement

Full Length Active Gallery

FLAG, which stands for Full Length Active Gallery, means ACROBiosystems's multi-pass transmembrane proteins (TPs) technology platforms. A gallery of full-length multi-pass TPs with native conformation are available to facilitate the process of targeted drugs and therapies development.
Discovery Solutions for Cell and Gene Therapy content piece image
Product
Advertisement

Discovery Solutions for Cell and Gene Therapy

As a leading manufacturer of recombinant proteins and other critical reagents to support the development of biomedicine, ACROBiosystems is proud to stand by you in the CGT journey.
Advertisement